By Chris Wack


Nano-X Imaging Ltd. said its deep-learning medical imaging analytics subsidiary, Nanox.AI, received FDA 510(k) clearance for its HealthOST device.

The company said the HealthOST is an AI software that provides qualitative and quantitative analysis of the spine from CT to support clinicians in the evaluation and assessment of musculoskeletal disease.

The FDA clearance is Nanox.AI's 10th for its AI clinical decision assist tools, and second FDA clearance for its vertebral compression fracture device.

Nano-X shares were up 9% to $10.53 in premarket trading.


Write to Chris Wack at chris.wack@wsj.com


(END) Dow Jones Newswires

04-28-22 0941ET